I wasn’t sure if FTD was normally granted based

I wasn’t sure if FTD was normally granted based on preclinical data? It is definitely encouraging that the FDA likes leronlimab so much.....but they should based on its safety profile and preclinical results. RP stayed last week that it was rare for preclinical results to be so great!

Please do your own due diligence. All my posts and comments are not to be considered investment advice.